MALACHITE INNOVATIONS, INC.

(MLCT)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

MALACHITE INNOVATIONS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

12/28/2021 | 04:07pm EDT

Item 8.01. Other Events.

We are furnishing the disclosure in this Item 8.01 in connection with the disclosure of information in a press release released on December 28, 2021 announcing that the U.S. Patent and Trademark Office (USPTO) has granted two patents to the Company for its cannabinoid glycoside prodrug, and that the Company has applied for a new patent under the Patent Cooperation Treaty (PCT) for its novel manufacturing process used to produce its proprietary cannabinoid glycosides. The Company's new patent application was filed with the USPTO and preserves our right to seek patent protection in 153 foreign nations that are signatories of the PCT. The press release is attached to this Current Report as Exhibit 99.1.

The information in this Item 8.01 (including Exhibit 99.1) is furnished pursuant to Item 8.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This Current Report will not be deemed an admission as to the materiality of any information in the Report that is required to be disclosed solely by Regulation FD.

Portions of this Current Report on Form 8-K may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. Although the Company believes any such statements are based on reasonable assumptions, there is no assurance that the actual outcomes will not be materially different due to a number of factors. Any such statements are made in reliance on the "safe harbor" protections provided under the Private Securities Litigation Reform Act of 1995. Additional information about significant risks that may impact the Company is contained in the Company's filings with the Securities and Exchange Commission and may be accessed at www.sec.gov. The Company is under no obligation, and expressly disclaims any obligation, to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Item 9.01 Financial Statements and Exhibits



Exhibit No.   Description

99.1            Press Release from Malachite Innovations, Inc., dated December 28,
              2021.
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses

All news about MALACHITE INNOVATIONS, INC.
05/13Malachite innovations announces closing of $3.0 million capital raise and initial esg a..
GL
05/13Malachite innovations announces closing of $3.0 million capital raise and initial esg a..
AQ
05/13MALACHITE INNOVATIONS, INC. : Entry into a Material Definitive Agreement, Completion of Ac..
AQ
05/13Malachite Innovations, Inc. announced that it has received $3 million in funding from T..
CI
05/12INSIDER BUY : Malachite Innovations
MT
05/10MALACHITE INNOVATIONS, INC. Management's Discussion and Analysis of Financial Conditio..
AQ
05/10Malachite Innovations, Inc. Reports Earnings Results for the First Quarter Ended March ..
CI
05/10Malachite Innovations, Inc. announced that it expects to receive $3 million in funding ..
CI
03/31MALACHITE INNOVATIONS, INC. - 10-KT - Management's Discussion and Analysis of Financial..
AQ
03/31Malachite Innovations, Inc. Reports Earnings Results for the Nine Months Ended December..
CI
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -0,88 M - -
Net cash 2021 0,85 M - -
P/E ratio 2021 -10,4x
Yield 2021 -
Capitalization 18,4 M 18,4 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 3
Free-Float 66,9%
Chart MALACHITE INNOVATIONS, INC.
Duration : Period :
Malachite Innovations, Inc. Technical Analysis Chart | MLCT | US56089M1071 | MarketScreener
Income Statement Evolution
Managers and Directors
Michael Cavanaugh Chief Executive Officer & Director
Richard McKilligan Controller, Chief Financial & Accounting Officer
Edward F. Feighan Executive Chairman
Brandon Zipp Chief Science Officer
Richard Frank Celeste Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MALACHITE INNOVATIONS, INC.-12.88%18
MODERNA, INC.-41.86%58 733
LONZA GROUP AG-24.79%44 437
IQVIA HOLDINGS INC.-21.85%41 736
SEAGEN INC.-8.54%26 026
ICON PUBLIC LIMITED COMPANY-26.61%18 478